KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Change in Taxes (2016 - 2025)

Historic Change in Taxes for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to -$365.0 million.

  • Amgen's Change in Taxes fell 78867.92% to -$365.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$2.1 billion, marking a year-over-year decrease of 10455.0%. This contributed to the annual value of -$2.1 billion for FY2025, which is 10455.0% down from last year.
  • As of Q4 2025, Amgen's Change in Taxes stood at -$365.0 million, which was down 78867.92% from $610.0 million recorded in Q3 2025.
  • Amgen's Change in Taxes' 5-year high stood at $610.0 million during Q3 2025, with a 5-year trough of -$2.4 billion in Q2 2025.
  • For the 5-year period, Amgen's Change in Taxes averaged around -$280.6 million, with its median value being $52.5 million (2021).
  • In the last 5 years, Amgen's Change in Taxes skyrocketed by 51153.85% in 2022 and then plummeted by 557857.14% in 2024.
  • Over the past 5 years, Amgen's Change in Taxes (Quarter) stood at -$135.0 million in 2021, then dropped by 14.81% to -$155.0 million in 2022, then plummeted by 1209.03% to -$2.0 billion in 2023, then surged by 102.61% to $53.0 million in 2024, then crashed by 788.68% to -$365.0 million in 2025.
  • Its Change in Taxes was -$365.0 million in Q4 2025, compared to $610.0 million in Q3 2025 and -$2.4 billion in Q2 2025.